Skip to main content
. 2016 Dec 8;7:194. doi: 10.3389/fpsyt.2016.00194

Table 2.

Available datasets.

Diagnostic measurements Number of samples
CSF basic diagnostics (WBC count, protein concentration, albumin quotient, and intrathecal immunoglobulin synthesis) 63
Intracellular synaptic and onconeural antigens (GAD, amphiphysin, Yo, Hu, Ri, Cv2/CRMP5, Ma1, Ma2, and SOX1) 29
Antibodies against neuronal cell surface antigens (NMDAR, AMPA-1/2-R, GABA-B-R, and VGKC-complex: LGI1 and CASPR2) 23
Electroencephalography data sets 61
Magnetic resonance imaging data sets 50a

aFor eight patients, only cranial computer tomography was available.

WBC, white blood cell; GAD, glutamic acid decarboxylase; Yo/Hu/Ri, abbreviations of first patients’ name; Cv2/CRMP5, anti-collapsin response-mediator protein; Ma1/Ma2, 37, and 40 kDa neuronal proteins; SOX1, sry-like high-mobility group box 1; NMDAR, N-methyl-d-aspartat-receptor; AMPA-1/2-R, α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor; GABA-B-R, γ-aminobutyric acid receptor; VGKC-complex, voltage-gated potassium channels complex; LGI1, leucine-rich glioma-inactivated 1; CASPR2, contactin-associated protein-like 2.